HLA-C and metastatic neoplasm: Differential gene expression analysis and subsequent GSEA comparing 22Rv1 metastatic tumors from mice treated with STEAP1-BBζ CAR T cell therapy to those treated with untransduced T cells showed negative enrichment of pathways involved in MHC, cytotoxic lymphocytes, and T cell activation (Supplementary Fig. 9a, b).